Height and Heart Disease

Reviews in Cardiovascular Medicine

Volumn 15, Issue 2, 2014, Pages 102-108

  Rosenbush, Stuart W ^a   Parker, Jeremy M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atrial fibrillation; Congestive heart failure; Coronary artery disease; Heart disease; Height; Marfan syndrome; Mitral valve prolapse

Indexed keywords

AORTA VALVE STENOSIS; BLOOD VESSEL DIAMETER; BODY HEIGHT; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; GROWTH HORMONE DEFICIENCY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; LUNG VOLUME; MARFAN SYNDROME; MITRAL VALVE PROLAPSE; PREVALENCE; REVIEW; VALVULAR HEART DISEASE; RISK FACTOR;

BODY HEIGHT; HEART DISEASES; HUMANS; RISK FACTORS;

EID: 84906318910     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: 10.3909/ricm0678     Document Type: Review

References (60)

1. Ogden CL, Fryar CD, Carroll MD, Flegal KM. Mean body weight, height, and body mass index, United States 1960-2002. Adv Data. 2004;347:1-17.
2. Hatton TJ, Bray BE. Long run trends in the heights of European men, 19th-20th centuries. Econ Hum Biol. 2010;8:405-413.
3. Mont L, Tamborero D, Elosua R, et al GIRAFA (Grup Integrat de Recerca en Fibril-lació Auricular) Investigators. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace. 2008;10:15-20. (Pubitemid 351767264)
4. Suzuki S, Yamashita T, Ohtsuka T, et al. Body size and atrial fibrillation in Japanese outpatients. Circ J. 2010;74:66-70.
5. Rosengren A, Hauptman PJ, Lappas G, et al. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J. 2009;30:1113-1120.
6. Friberg J, Scharling H, Gadsbøll N, Jensen GB. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). Am J Cardiol. 2003;92:1419-1423. (Pubitemid 37532563)
7. Dublin S, French B, Glazer NL, et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med. 2006;166:2322-2328. (Pubitemid 44833356)
8. Hanna IR, Heeke B, Bush H, et al. The relationship between stature and the prevalence of atrial fibrillation in patients with left ventricular dysfunction. J Am Coll Cardiol. 2006;47:1683-1688.
9. Akinkuolie AO, Aleardi M, Ashaye AO, et al. Height and risk of heart failure in the Physicians' Health Study. Am J Cardiol. 2012;109:994-997.
10. Vasan RS, Larson MG, Levy D, et al. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. Circulation. 1997;96:1863-1873. (Pubitemid 27400746)
11. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82:2N-9N. (Pubitemid 28507114)
12. Tsang TS, Barnes ME, Bailey KR, et al. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc. 2001;76:467-475. (Pubitemid 32423130)
13. Pritchett AM, Jacobsen SJ, Mahoney DW, et al. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol. 2003;41:1036-1043. (Pubitemid 36315550)
14. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994;89:724-730. (Pubitemid 24056200)
15. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96:2455-2461. (Pubitemid 27425856)
16. Guglielmini C, Chetboul V, Pietra M, et al. Influence of left atrial enlargement and body weight on the development of atrial fibrillation: retrospective study on 205 dogs. Vet J. 2000;160:235-241.
17. Meijler FL, van der Tweel I. Comparative study of atrial fibrillation and AV conduction in mammals. Heart Vessels Suppl. 1987;2:24-31.
18. Zou R, Kneller J, Leon LJ, Nattel S. Substrate size as a determinant of fibrillatory activity maintenance in a mathematical model of canine atrium. Am J Physiol Heart Circ Physiol. 2005;289:H1002-H1012. (Pubitemid 41208940)
19. Vasan RS, Larson MG, Levy D. Determinants of echocardiographic aortic root size. The Framingham Heart Study. Circulation. 1995;91:734-740.
20. Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476-485.
21. McDowell MA, Fryar CD, Ogden CL. Anthropometric reference data for children and adults: United States, 1988-1994. Vital Health Stat 11. 2009;249:1-68.
22. Taub CC, Stoler JM, Perez-Sanz T, et al. Mitral valve prolapse in Marfan syndrome: an old topic revisited. Echocardiography. 2009;26:357-364.
23. Kulick DL. Mitral valve prolapse (MVP). MedicineNet Web site. http://www.medicinenet.com/mitral-valve-prolapse/article.htm. Accessed April 15, 2014.
24. Savage DD, Garrison RJ, Devereux RB, et al. Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study. Am Heart J. 1983;106:571-576. (Pubitemid 13050630)
25. Schutte JE, Gaffney FA, Blend L, Blomqvist CG. Distinctive anthropometric characteristics of women with mitral valve prolapse. Am J Med. 1981;71:533-538. (Pubitemid 12140417)
26. Flack JM, Kvasnicka JH, Gardin JM, et al. Anthropometric and physiologic correlates of mitral valve prolapse in a biethnic cohort of young adults: the CARDIA study. Am Heart J. 1999;138(3 Pt 1):486-492. (Pubitemid 29428771)
27. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999;341:1-7. (Pubitemid 29293713)
28. Hickey AJ, Narunsky L, Wilcken DE. Bodily habitus and mitral valve prolapse. Aust N Z J Med. 1985;15:326-330. (Pubitemid 15020608)
29. Theal M, Sleik K, Anand S, et al. Prevalence of mitral valve prolapse in ethnic groups. Can J Cardiol. 2004;20:511-515. (Pubitemid 38714684)
30. Araujo CG, Chaves CP. Adult women with mitral valve prolapse are more flexible. Br J Sports Med. 2005;39:720-724. (Pubitemid 41406584)
31. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630-634. (Pubitemid 27116107)
32. Martin-Du Pan RC, Benoit R, Girardier L. The role of body position and gravity in the symptoms and treatment of various medical diseases. Swiss Med Wkly. 2004;134:543-551. (Pubitemid 39487029)
33. Langenberg C, Hardy R, Kuh D, Wadsworth ME. Influence of height, leg and trunk length on pulse pressure, systolic and diastolic blood pressure. J Hypertens. 2003;21:537-543. (Pubitemid 36418965)
34. Nwasokwa ON, Weiss M, Gladstone C, Bodenheimer MM. Higher prevalence and greater severity of coronary disease in short versus tall men referred for coronary arteriography. Am Heart J. 1997;133:147-152.
35. Hebert PR, Rich-Edwards JW, Manson JE, et al. Height and incidence of cardiovascular disease in male physicians. Circulation . 1993;88(4 Pt 1):1437-1443. (Pubitemid 23296889)
36. Langenberg C, Shipley MJ, Batty GD, Marmot MG. Adult socioeconomic position and the association between height and coronary heart disease mortality: findings from 33 years of follow-up in the Whitehall Study. Am J Public Health. 2005;95:628-632. (Pubitemid 40411138)
37. Hrubec Z, Zukel WJ. Epidemiology of coronary heart disease among young army males of World War II. Am Heart J. 1974;87:722-730.
38. Palmer JR, Rosenberg L, Shapiro S. Stature and the risk of myocardial infarction in women. Am J Epidemiol. 1990;132:27-32. (Pubitemid 20203299)
39. Lawlor DA, Taylor M, Davey Smith G, et al. Associations of components of adult height with coronary heart disease in postmenopausal women: the British women's heart and health study. Heart. 2004;90:745-749. (Pubitemid 38813632)
40. Rich-Edwards JW, Manson JE, Stampfer MJ, et al. Height and the risk of cardiovascular disease in women. Am J Epidemiol. 1995;142:909-917.
41. Wamala SP, Mittleman MA, Horsten M, et al. Short stature and prognosis of coronary heart disease in women. J Intern Med. 1999;245:557-563. (Pubitemid 29278863)
42. Paajanen TA, Oksala NKJ, Kuukasjärvi P, Karhunen PJ. Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis. Eur Heart J. 2010;31:1802-1809.
43. Kelly RF, Mohanty J, Hashim AS, Parrillo JE. Association between height and coronary artery disease in black men and women. Am J Cardiol. 2000;85:1253-1255. (Pubitemid 30232826)
44. Liao Y, McGee DL, Cao G, Cooper RS. Short stature and risk of mortality and cardiovascular disease: negative findings from the NHANES I epidemiologic follow-up study. J Am Coll Cardiol. 1996;27:678-682. (Pubitemid 26080390)
45. Samaras TT, Elrick H. Height, body size, and longevity: is smaller better for the human body? West J Med. 2002;176:206-208. (Pubitemid 37505035)
46. Gunnarsdottir I, Birgisdottir BE, Thorsdottir I, et al. Size at birth and coronary artery disease in a population with high birth weight. Am J Clin Nutr. 2002;76:1290-1294. (Pubitemid 35416564)
47. Forsén T, Eriksson JG, Tuomilehto J, et al. Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ. 1999;319:1403-1407.
48. Fisher LD, Kennedy JW, Davis KB, et al. Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg. 1982;84:334-341. (Pubitemid 13096733)
49. Dodge JT Jr, Brown BG, Bolson EL, Dodge HT. Lumen diameter of normal human coronary arteries. Influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation. Circulation. 1992;86:232-246.
50. Johnson MR. A normal coronary artery: what size is it? Circulation. 1992;86:331-333.
51. Strachan DP. Ventilatory function, height, and mortality among lifelong non-smokers. J Epidemiol Community Health. 1992;46:66-70.
52. Walker M, Shaper AG, Phillips AN, Cook DG. Short stature, lung function and risk of a heart attack. Int J Epidemiol. 1989;18:602-606. (Pubitemid 19268603)
53. Cook NR, Hebert PR, Satterfield S, et al. Height, lung function, and mortality from cardiovascular disease among the elderly. Am J Epidemiol. 1994;139:1066-1076. (Pubitemid 24170634)
54. Chu NF, Rimm EB, Wang DJ, et al. Relationship between anthropometric variables and lipid levels among school children: The Taipei Children Heart Study. Int J Obes Relat Metab Disord. 1998;22:66-72. (Pubitemid 28036591)
55. Kouda K, Nakamura H, Fan W, Takeuchi H. Negative relationships between growth in height and levels of cholesterol in puberty: a 3-year follow-up study. Int J Epidemiol. 2003;32:1105-1110. (Pubitemid 38072705)
56. Jenkins LR. Coronary heart disease and short stature. Br Med J. 1977;2:1603.
57. Juul A, Scheike T, Davidsen M, et al. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation. 2002;106:939-944. (Pubitemid 34925327)
58. Cannavò S, Marini F, Curtò L, et al. High prevalence of coronary calcifications and increased risk for coronary heart disease in adults with growth hormone deficiency. J Endocrinol Invest. 2011;34:32-37.
59. Colao A. The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin Endocrinol (Oxf). 2008;69:347-358.
60. L'Allemand D, Eiholzer U, Schlumpf M, et al. Cardiovascular risk factors improve during 3 years of growth hormone therapy in Prader-Willi syndrome. Eur J Pediatr. 2000;159:835-842.